Almena G Prioleau, CACII Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 145 Bryant Dr, Saint Stephen, SC 29479 Phone: 843-567-4867 |
News Archive
Researchers have discovered a new genetic test which could help predict cancer recurrence - paving the way for more precise, personalized treatments.
COVID-19 vaccines are effective at preventing hospitalizations and emergency department visits caused by the Delta variant, according to data from a national study.
According to official sources in China, at least one person has died from bird flu, confirming widespread suspicion that the deadly virus has now spread in people in another large Asian country where it might prove hard to contain.
Epizyme, Inc., a clinical-stage company developing novel epigenetic therapies, announced today that updated efficacy and safety data from the fully enrolled cohort of epithelioid sarcoma (ES) patients in its ongoing Phase 2 trial of tazemetostat will be presented in a poster discussion session at the European Society for Medical Oncology (ESMO) 2018 Congress to be held October 19-23 in Munich, Germany.
Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.
› Verified 2 days ago